Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as COVID-19 vaccines, and the increasing healthcare expenditure.
Highlighted with 59 tables and 54 figures, this 141-page report "Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire Asia Pacific preventive vaccines market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific preventive vaccines market in every aspect of the classification from perspectives of Vaccine Type, Disease, Administration, Patient, and Country.
Based on Vaccine Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Live/Attenuated Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• Conjugate Vaccines
• mRNA Vaccines
• Recombinant Vector Vaccines
• Other Vaccines
Based on Disease, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Pneumococcal Disease
• Poliovirus
• Hepatitis
• Influenza
• Measles, Mumps, and Rubella (MMR)
• Varicella
• Human Papilloma Virus
• COVID-19
• Other Diseases
By Administration, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Intramuscular Route
• Subcutaneous Route
• Oral Route
• Intravenous Injection
• Other Administration Routes
By Patient, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Pediatric Vaccines
o Pneumococcal
o Measles, Mumps, and Rubella (MMR)
o Varicella
o Hepatitis
o Poliovirus
o Haemophilus Influenzae B (HIB)
o Other Diseases
• Adult Vaccines
o Influenza
o Cervical Cancer
o Hepatitis
o Zoster
o Other Diseases
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Vaccine Type, Disease, and Administration over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
AstraZeneca plc
Bavarian Nordic A/S
China National Biotec Group Company Ltd.
CSL Ltd.
Daiichi Sankyo Co. Ltd
Emergent BioSolutions Inc.
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co.
Moderna Inc.
Novavax, Inc.
Pfizer Inc.
Sanofi SA
Takeda Pharmaceutical Co. Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 27
2.2 Major Growth Drivers 31
2.3 Market Restraints and Challenges 37
2.4 Emerging Opportunities and Market Trends 40
2.5 Porter's Fiver Forces Analysis 44
3 Segmentation of Asia Pacific Market by Vaccine Type 48
3.1 Market Overview by Vaccine Type 48
3.2 Live/Attenuated Vaccines 50
3.3 Inactivated Vaccines 51
3.4 Subunit Vaccines 52
3.5 Toxoid Vaccines 53
3.6 Conjugate Vaccines 54
3.7 mRNA Vaccines 55
3.8 Recombinant Vector Vaccines 56
3.9 Other Vaccines 57
4 Segmentation of Asia Pacific Market by Disease 58
4.1 Market Overview by Disease 58
4.2 Pneumococcal Disease 60
4.3 Poliovirus 61
4.4 Hepatitis 62
4.5 Influenza 63
4.6 Measles, Mumps, and Rubella (MMR) 64
4.7 Varicella 65
4.8 Human Papilloma Virus 66
4.9 COVID-19 67
4.10 Other Diseases 68
5 Segmentation of Asia Pacific Market by Administration 69
5.1 Market Overview by Administration 69
5.2 Intramuscular Route 71
5.3 Subcutaneous Route 72
5.4 Oral Route 73
5.5 Intravenous Injection 74
5.6 Other Administration Routes 75
6 Segmentation of Asia Pacific Market by Patient 76
6.1 Market Overview by Patient 76
6.2 Pediatric Vaccines 78
6.3 Adult Vaccines 80
7 Asia-Pacific Market 2022-2032 by Country 82
7.1 Overview of Asia-Pacific Market 82
7.2 Japan 85
7.3 China 89
7.4 Australia 93
7.5 India 96
7.6 South Korea 99
7.7 Rest of APAC Region 102
8 Competitive Landscape 104
8.1 Overview of Key Vendors 104
8.2 New Product Launch, Partnership, Investment, and M&A 107
8.3 Company Profiles 108
AstraZeneca plc 108
Bavarian Nordic A/S 110
China National Biotec Group Company Ltd. 113
CSL Ltd. 115
Daiichi Sankyo Co. Ltd 117
Emergent BioSolutions Inc. 119
GlaxoSmithKline plc 121
Johnson & Johnson 125
Merck & Co. 127
Moderna Inc. 129
Novavax, Inc. 130
Pfizer Inc. 132
Sanofi SA 136
Takeda Pharmaceutical Co. Ltd. 139
RELATED REPORTS 141
The pandemic proved to be a more extended phenomenon in Asia Pacific than in other regions, with some countries' travel industry negatively impacted in both 2020 and 2021, and China, the biggest market, seeing declines in both 2020 and 2022. A strong recovery has been underway since 2023, although m...
Metal packaging continues to be an important, and growing, pack type in Asia Pacific, led by metal beverage cans for soft and alcoholic drinks, which accounted for the bulk of new metal packaging sales in the region over 2018-2023. While metal bottles have been enjoying a boom in the Chinese beer ma...
Sales of alcoholic drinks in Asia Pacific suffered two bad years in the pandemic, in both 2020 and 2022, the latter mainly due to the return of COVID-19 in China, the dominant country market. Growth in 2023 was also subdued, with Japan and Vietnam in decline and China only seeing a relatively weak r...
The coffeeshop landscape is increasingly competitive in Asia Pacific with many brands seeking to have a share of the pie. By exploring innovative channel concepts beyond the traditional café space, this will provide new channel strategy for brands to win consumers and appeal to changing consumer val...
While product value for consumers across Asia Pacific was traditionally defined by price, quality and quantity, a broader concept of value is emerging reflecting a blend of financial and emotional considerations that shape purchasing choices. By understanding how consumers in Asia Pacific are spendi...
Market Overview
The Asia Pacific Waste Recycling Services Market is set for substantial growth from 2024 to 2034, driven by the increasing emphasis on sustainability, stringent environmental regulations, and the growing need for efficient waste management solutions. The market is projec...
Market Overview
The Asia Pacific Pet Grooming Market is expected to experience substantial growth from 2024 to 2034, driven by the increasing pet ownership, rising awareness of pet hygiene, and growing demand for premium pet care products. As the pet care industry continues to expand, g...
Market Overview
The Asia Pacific Anti-Tank Missile System Market is poised for significant growth from 2024 to 2034, driven by escalating defense budgets, rising geopolitical tensions, and the need for advanced military technologies. The market is projected to achieve a valuation of USD...
Market Overview
The Asia Pacific Unmanned Underwater Vehicles (UUVs) Market is projected to witness significant growth from 2024 to 2034, driven by the increasing demand for autonomous exploration and surveillance capabilities across commercial, defense, and scientific research sectors....
Market Overview
The Asia Pacific Mirror Coatings Market is set to experience substantial growth from 2024 to 2034, driven by rising demand across diverse end-use industries, including automotive, solar power, and architectural applications. The market is projected to reach USD XX.XX bil...